Results for patient specimens that were subjected to immunophenotyping
| Disease classification by immunophenotyping . | No. of samples . |
|---|---|
| Total No. of samples | 307 |
| AML | 91 |
| ALL | 128 |
| MPAL | 5 |
| No evidence of disease | 62 |
| Inconclusive results | 21 |
| Subclassifications of AML | |
| AML | 58 |
| Myeloid leukemia associated with Down syndrome | 4 |
| APL | 6 |
| FAB AML classification | |
| M4/M5 | 17 |
| M6 | 1 |
| M7 | 5 |
| Subclassifications of ALL | |
| B-cell ALL | 100 |
| T-cell ALL | 28 |
| Disease classification by immunophenotyping . | No. of samples . |
|---|---|
| Total No. of samples | 307 |
| AML | 91 |
| ALL | 128 |
| MPAL | 5 |
| No evidence of disease | 62 |
| Inconclusive results | 21 |
| Subclassifications of AML | |
| AML | 58 |
| Myeloid leukemia associated with Down syndrome | 4 |
| APL | 6 |
| FAB AML classification | |
| M4/M5 | 17 |
| M6 | 1 |
| M7 | 5 |
| Subclassifications of ALL | |
| B-cell ALL | 100 |
| T-cell ALL | 28 |
APL, acute promyelocytic leukemia; FAB, French-American-British [classification system]; M4, acute myelomonocytic leukemia; M5, acute monocytic leukemia; M6, acute erythroid leukemia; M7, acute megakaryoblastic leukemia; MPAL, mixed-phenotype acute leukemia.